Fujifilm Diosynth Biotechnologies has received a renewal of its Manufacturer’s License from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The license authorizes commercial manufacturing at the company’s Billingham, UK site.   The inspection included the new cGMP mammalian cell culture manufacturing facility, which will primarily employ single-use technologies. It will initially offer 200L and 1000L single-use bioreactors, with 2000L bioreactors planned for 2014. The licens...